Racial and Sex Inequities in the Use of and Outcomes after Left Ventricular Assist Device Implantation among Medicare Beneficiaries

Thomas M. Cascino, Sriram Somanchi, Monica Colvin, Grace S. Chung, Alexander A. Brescia, Michael Pienta, Michael P. Thompson, James W. Stewart, Devraj Sukul, Daphne C. Watkins, Francis D. Pagani, Donald S. Likosky, Keith D. Aaronson, Jeffrey S. McCullough

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Importance: While left ventricular assist devices (LVADs) increase survival for patients with advanced heart failure (HF), racial and sex access and outcome inequities remain and are poorly understood. Objectives: To assess risk-adjusted inequities in access and outcomes for both Black and female patients and to examine heterogeneity in treatment decisions among patients for whom clinician discretion has a more prominent role. Design, Setting, and Participants: This retrospective cohort study of 12310 Medicare beneficiaries used 100% Medicare Fee-for-Service administrative claims. Included patients had been admitted for heart failure from 2008 to 2014. Data were collected from July 2007 to December 2015 and analyzed from August 23, 2020, to May 15, 2022. Exposures: Beneficiary race and sex. Main Outcomes and Measures: The propensity for LVAD implantation was based on clinical risk factors from the 6 months preceding HF admission using XGBoost and the synthetic minority oversampling technique. Beneficiaries with a 5% or greater probability of receiving an LVAD were included. Logistic regression models were estimated to measure associations of race and sex with LVAD receipt adjusting for clinical characteristics and social determinants of health (eg, distance from LVAD center, Medicare low-income subsidy, neighborhood deprivation). Next, 1-year mortality after LVAD was examined. Results: The analytic sample included 12310 beneficiaries, of whom 22.9% (n = 2819) were Black and 23.7% (n = 2920) were women. In multivariable models, Black beneficiaries were 3.0% (0.2% to 5.8%) less likely to receive LVAD than White beneficiaries, and women were 7.9% (5.6% to 10.2%) less likely to receive LVAD than men. Individual poverty and worse neighborhood deprivation were associated with reduced use, 2.9% (0.4% to 5.3%) and 6.7% (2.9% to 10.5%), respectively, but these measures did little to explain observed disparities. The racial disparity was concentrated among patients with a low propensity score (propensity score <0.52). One-year survival by race and sex were similar on average, but Black patients with a low propensity score experienced improved survival (7.2% [95% CI, 0.9% to 13.5%]). Conclusions and Relevance: In this cohort study of Medicare beneficiaries hospitalized for HF, disparities in LVAD use by race and sex existed and were not explained by clinical characteristics or social determinants of health. The treatment and post-LVAD survival by race were equivalent among the most obvious LVAD candidates. However, there was differential use and outcomes among less clear-cut LVAD candidates, with lower use but improved survival among Black patients. Inequity in LVAD access may have resulted from differences in clinician decision-making because of systemic racism and discrimination, implicit bias, or patient preference..

Original languageEnglish
Pages (from-to)E2223080
JournalJAMA Network Open
Volume5
Issue number7
DOIs
StatePublished - Jul 27 2022

Fingerprint

Dive into the research topics of 'Racial and Sex Inequities in the Use of and Outcomes after Left Ventricular Assist Device Implantation among Medicare Beneficiaries'. Together they form a unique fingerprint.

Cite this